Discover efficiency, reliability and modular automation in the first multi-dye, nucleic acid amplification technology for blood and plasma.
Although humans are not the primary hosts for WNV, they may become infected through a mosquito bite. Most infections are usually asymptomatic, however the virus can be transmitted through blood, tissue and organ donations.
Transmission of WNV can pose particular danger for immunocompromised patients, causing neuroinvasive complications such as meningitis, encephalitis, meningoencephalitis, or acute flaccid paralysis, which can lead to irreversible neurological damage, coma, and death.1
To enable early and accurate detection of WNV, Roche Molecular offers the cobas® TaqScreen West Nile Virus Test and cobas® West Nile Virus test for the direct detection of WNV RNA for donor screening and provides robust coverage for WNV flaviviruses that cause transfusion transmitted infectious diseases.
Discover efficiency, reliability and modular automation in the first multi-dye, nucleic acid amplification technology for blood and plasma.
Transform your testing experience for IVD applications—just 2 simple user interactions per run and up to 8 hours of walk-away time.
Unparalleled performance with minimal operator interaction revolutionizes the future of high-throughput applications.
References